Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MYC overexpression
i
Other names:
MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4609
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MYC overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression
Diffuse Large B Cell Lymphoma
tisagenlecleucel-T
Resistant: C3 – Early Trials
tisagenlecleucel-T
Resistant
:
C3
tisagenlecleucel-T
Resistant: C3 – Early Trials
tisagenlecleucel-T
Resistant
:
C3
MYC overexpression
Mediastinal B Cell Lymphoma
MYC overexpression
Mediastinal B Cell Lymphoma
lisocabtagene maraleucel
Resistant: C3 – Early Trials
lisocabtagene maraleucel
Resistant
:
C3
lisocabtagene maraleucel
Resistant: C3 – Early Trials
lisocabtagene maraleucel
Resistant
:
C3
MYC overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression
Diffuse Large B Cell Lymphoma
azacitidine oral
Sensitive: C3 – Early Trials
azacitidine oral
Sensitive
:
C3
azacitidine oral
Sensitive: C3 – Early Trials
azacitidine oral
Sensitive
:
C3
MYC overexpression
Cervical Cancer
MYC overexpression
Cervical Cancer
GS-626510
Sensitive: D – Preclinical
GS-626510
Sensitive
:
D
GS-626510
Sensitive: D – Preclinical
GS-626510
Sensitive
:
D
MYC overexpression
Mantle Cell Lymphoma
MYC overexpression
Mantle Cell Lymphoma
TG-1701
Sensitive: D – Preclinical
TG-1701
Sensitive
:
D
TG-1701
Sensitive: D – Preclinical
TG-1701
Sensitive
:
D
MYC overexpression
Multiple Myeloma
MYC overexpression
Multiple Myeloma
bortezomib
Resistant: D – Preclinical
bortezomib
Resistant
:
D
bortezomib
Resistant: D – Preclinical
bortezomib
Resistant
:
D
MYC overexpression
Thyroid Gland Carcinoma
MYC overexpression
Thyroid Gland Carcinoma
MLN8237
Sensitive: D – Preclinical
MLN8237
Sensitive
:
D
MLN8237
Sensitive: D – Preclinical
MLN8237
Sensitive
:
D
MYC overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression
Diffuse Large B Cell Lymphoma
INCB57643
Sensitive: D – Preclinical
INCB57643
Sensitive
:
D
INCB57643
Sensitive: D – Preclinical
INCB57643
Sensitive
:
D
MYC overexpression
Mantle Cell Lymphoma
MYC overexpression
Mantle Cell Lymphoma
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
MYC overexpression
Gastric Cancer
MYC overexpression
Gastric Cancer
WB100
Sensitive: D – Preclinical
WB100
Sensitive
:
D
WB100
Sensitive: D – Preclinical
WB100
Sensitive
:
D
MYC overexpression
Pancreatic Ductal Adenocarcinoma
MYC overexpression
Pancreatic Ductal Adenocarcinoma
WB100
Sensitive: D – Preclinical
WB100
Sensitive
:
D
WB100
Sensitive: D – Preclinical
WB100
Sensitive
:
D
MYC overexpression
Acute Myelogenous Leukemia
MYC overexpression
Acute Myelogenous Leukemia
WB100
Sensitive: D – Preclinical
WB100
Sensitive
:
D
WB100
Sensitive: D – Preclinical
WB100
Sensitive
:
D
MYC overexpression
Non Small Cell Lung Cancer
MYC overexpression
Non Small Cell Lung Cancer
MRT-2359
Sensitive: D – Preclinical
MRT-2359
Sensitive
:
D
MRT-2359
Sensitive: D – Preclinical
MRT-2359
Sensitive
:
D
MYC overexpression
Non Small Cell Lung Cancer
MYC overexpression
Non Small Cell Lung Cancer
ROS1 inhibitor
Resistant: D – Preclinical
ROS1 inhibitor
Resistant
:
D
ROS1 inhibitor
Resistant: D – Preclinical
ROS1 inhibitor
Resistant
:
D
MYC overexpression
Lymphoma
MYC overexpression
Lymphoma
brusatol
Sensitive: D – Preclinical
brusatol
Sensitive
:
D
brusatol
Sensitive: D – Preclinical
brusatol
Sensitive
:
D
MYC overexpression
Triple Negative Breast Cancer
MYC overexpression
Triple Negative Breast Cancer
PD-L1 inhibitor + MYC inhibitor
Sensitive: D – Preclinical
PD-L1 inhibitor + MYC inhibitor
Sensitive
:
D
PD-L1 inhibitor + MYC inhibitor
Sensitive: D – Preclinical
PD-L1 inhibitor + MYC inhibitor
Sensitive
:
D
MYC overexpression
Hepatocellular Cancer
MYC overexpression
Hepatocellular Cancer
HX301
Sensitive: D – Preclinical
HX301
Sensitive
:
D
HX301
Sensitive: D – Preclinical
HX301
Sensitive
:
D
MYC overexpression
Small Cell Lung Cancer
MYC overexpression
Small Cell Lung Cancer
ICX-101
Sensitive: D – Preclinical
ICX-101
Sensitive
:
D
ICX-101
Sensitive: D – Preclinical
ICX-101
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login